Summary
Johnson & Johnson announced its second-quarter financial results for the period ended June 28, 2026, via a press release filed on July 15, 2026. This 8-K filing primarily serves to furnish the details of this earnings announcement to the SEC, providing investors with key operational and financial data. Investors should review the attached press release (Exhibit 99.1) and supplementary sales data (Exhibit 99.2) for a comprehensive understanding of the Company's performance during the quarter.
Key Highlights
- 1Johnson & Johnson released its second-quarter 2026 financial results on July 15, 2026.
- 2The filing contains a press release detailing sales and earnings for the quarter ended June 28, 2026.
- 3Investors can access unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the quarter and six months ended June 28, 2026.
- 4The primary purpose of this 8-K is to report the Company's financial performance as per Item 2.02.
- 5Exhibit 99.1 is the press release announcing the Q2 2026 results.
- 6Exhibit 99.2 provides detailed financial statements and sales data for the period.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially report Johnson & Johnson's financial results for the second quarter ended June 28, 2026, as announced in their press release.
The specific sales and earnings figures for the second quarter ended June 28, 2026, are detailed in the press release (Exhibit 99.1) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2) attached to this 8-K filing.
This particular 8-K filing focuses on the announcement of financial results. For information on strategic initiatives or significant business developments, investors should refer to other sections of Johnson & Johnson's SEC filings or their official investor relations communications.
The press release announcing the second-quarter results was issued on July 15, 2026.